BTC-2.10%
Uncategorized
Humana Shares Climb with Medicare Payment Hike
The decision to raise Medicare Advantage plan payments by over $25 billion has led to a positive response in the stock market.
Editorial disclosureRead more
All reviews, research, news and assessments of any kind on The Tokenist are compiled using a strict editorial review process by our editorial team. Neither our writers nor our editors receive direct compensation of any kind to publish information on tokenist.com. Our company, Tokenist Media LLC, is community supported and may receive a small commission when you purchase products or services through links on our website. Click here for a full list of our partners and an in-depth explanation on how we get paid.
The U.S. government has taken a notable step by increasing payments to private Medicare Advantage plans by more than $25 billion. This move, which exceeds the initial proposal made in January, is a result of extensive advocacy from insurance companies.
Insurance Industry Secures Average Payment Increase of 5.06%
Despite facing increased scrutiny in Washington, the insurance industry has successfully secured an average payment increase of 5.06%, more than double the originally proposed rate.
This development is expected to have significant implications for major U.S. health insurers, including UnitedHealth Group Inc. (NYSE: UNH), CVS Health Corp. (NYSE: CVS), and Humana Inc. (NYSE: HUM), whose shares have risen following the announcement.
Join our Telegram group and never miss a breaking digital asset story.
Humana’s Stock Gains in Premarket
Following the announcement of increased payments to Medicare Advantage plans, shares of major health insurers have experienced notable movements.
Specifically, Humana Inc. saw its stock gain in premarket trading. As of April 8, 2025, at 08:46 EDT, the closing price stands at $254.71, with the latest premarket price reaching $301.75.
Humana’s stock performance is influenced by its key metrics, including a dividend rate of $3.54 and a yield of 1.39%. With a market cap of $30.74 billion and a trailing P/E ratio of 25.52, the company remains a significant player in the health insurance sector.
Analysts have provided a target high price of $402.23 and a target low price of $241.00, with a recommendation to hold the stock, reflecting a balanced outlook for investors.
Disclaimer: The author does not hold or have a position in any securities discussed in the article. All stock prices were quoted at the time of writing.
Tim Fries
Tim Fries is the cofounder of The Tokenist. He has a B. Sc. in Mechanical Engineering from the University of Michigan, and an MBA from the University of Chicago Booth School of Business. Tim served as a Senior Associate on the investment team at RW Baird's US Private Equity division, and is also the co-founder of Protective Technologies Capital, an investment firm specializing in sensing, protection and control solutions.
